Advantages of F (ab') 2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E.
Transplantation Proceedings 23(1 Part 1): 270-271
1991
ISSN/ISBN: 0041-1345 PMID: 1824981 Document Number: 381385
Document emailed within 1 workday
Related Documents
Zimmer, A.M.; Kazikiewicz, J.M.; Rosen, S.T.; Spies, S.M. 1987: Pharmacokinetics of 99mTc(Sn)- and 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice Cancer Research 47(6): 1691-1694Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Han, W.R.; Zhan, Y.; Murray-Segal, L.J.; Brady, J.L.; Lew, A.M.; Mottram, P.L. 2000: Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice Transplantation 70(1): 168-174
Moroz, C.; Zaspin, E.; Shohat, B. 1996: An immunosuppressive effect of anti-p43 monoclonal antibody on human xenogeneic graft versus host response is mediated by CD8+ T cells Transplantation Proceedings 28(6): 3196-3198
Maeda, T.; Nomoto, K. 1995: Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels Journal of Rheumatology 22(12): 2259-2265
Yoshimura, N.; Lee, C.J.; Shiho, O.; Kita, M.; Imanishi, J.; Oka, T. 1995: Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells Transplantation Proceedings 27(1): 390-391
Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C. 2010: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 795-798
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Tsuji, T.; Kimura, Y.; Murakami, T.; Sasaki, K.; Shinozaki, F. 1990: An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231 Gan no Rinsho. Japan Journal of Cancer Clinics 36(7): 783-786
Gutstein, N.L.; Wofsy, D. 1986: Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells Journal of Immunology 137(11): 3414-3419
Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Yuan, J.; Liao, Y.-h.; Wang, Z.-h.; Cheng, X.; Zhang, J.-h.; Dong, J.-h.; Wang, M. 2005: Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice Zhonghua Yi Xue Za Zhi 85(47): 3346-3349
Lee, C.H.; Suh, C.H.; Lee, J.; Kim, Y.T.; Lee, S.K. 2003: The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells Clinical and Experimental Rheumatology 21(3): 291-300
Juhl, H.; Sievers, M.; Baltzer, K.; Helmig, F.; Wolf, H.; Brenner, W.; Kalthoff, H. 1995: A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach Cancer Research 55(23 Suppl): 5749s-5755s
Chattopadhyay, P.; Kaveri, S.V.; Byars, N.; Starkey, J.; Ferrone, S.; Raychaudhuri, S. 1991: Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1 Cancer Research 51(22): 6045-6051
Andratschke, M.; Gildehaus, F.Josef.; Johannson, V.; Schmitt, B.; Mack, B.; Reisbach, G.; Lang, S.; Lindhofer, H.; Zeidler, R.; Wollenberg, B.; Luebbers, C.W. 2007: Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody Anticancer Research 27(1a): 431-436
Chiorazzi, N.; Tung, A.S.; Eshhar, N.; Katz, D.H. 1977: Hapten-specific IgE antibody responses in mice. VIII. a possible new mechanism by which anti-lymphocyte serum enhances IgE antibody synthesis in vivo Journal of Immunology 119(2): 685-693
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Chen, B.; Cai, X.J.; Zhou, S.J. 1994: Antitumor activity of monoclonal antibody MI2 against immunosuppressive acidic protein in vitro Zhonghua Nei Ke Za Zhi 33(8): 531-533